Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
Why Is Robotic Surgery-Focused Penny Stock Asensus Surgical Trading Higher On Friday?
KARL STORZ Endoscopy-America has agreed to acquire Asensus Surgical for $0.35 per share, representing a 67% premium. This acquisition will bolster KARL STORZ's robotic surgical market presence.
BNPL Company Affirm Launches New Payment Options To Boost Flexibility
Affirm Holdings, Inc announced new payment options, Pay in 2 and Pay in 30, for its app users. These options offer flexibility and cater to consumer budget preferences, leading to increased cart conversion and partnerships with companies such as Alterra Mountain Company. AFRM stock has gained 93% in the last year.
Blowout May Jobs Data ‘Closes The Door On A July Rate Cut’: 6 Economists Make Best Guesses On Fed’s Next Move
US labor market resilient in May with a surge of 272,000 nonfarm payrolls, exceeding forecast of 180,000. Unemployment rate rose to 4%, wages up 4.1%.
Bitcoin, Ethereum ETF Could Make ‘June A Really Good Month For Altcoins,’ Predicts Veteran Trader
The strong performance of Bitcoin (CRYPTO: BTC) spot ETFs and the upcoming Ethereum (CRYPTO: ETH) spot ET
Wall Street Reacts To Hot Jobs Report: Stocks Swing As Traders Abandon July Rate Cut Hopes
May labor market report: strong job gains and wage growth, reduces chances of rate cut. Interest-rate sensitive sectors underperform. Top risers: APD, URI, LLY, HUBB, ADP. Top losers: GEN, SHW, FCX, AMT.
Codelco Seeks Partner for Maricunga Lithium Project, Targeting 2030 Production
The Maricunga site is expected to supply a substantial amount of lithium — an essential metal in electric vehicle (EV) batteries.
AbbVie’s Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance patient access and incentivize development.
EXCLUSIVE: GameStop Stock In Spotlight With Roaring Kitty’s YouTube Return, 75% Of Investors Say Shares Will Trade Above This Price After Stream
Investors are showing high optimism in GameStop stock ahead of Roaring Kitty's return to YouTube. Here are the price predictions on the stock.
Alibaba Projects $60B GMV for 2024, Plans New Business Model Breakthroughs
Alibaba.com, a B2B platform, aims for $60B GMV in 2024, 20% increase from $50B in 2023. President cites need for new business model breakthroughs.